Yann d’Hervé Takes Helm of Evonik’s Health Care Business

Yann d’Hervé Takes Helm of Evonik’s Health Care Business

(IN BRIEF) Yann d’Hervé has been appointed to lead Evonik’s Health Care business line starting July 1st, transitioning from his previous role as Head of Care Solutions within the Nutrition & Care division. With extensive experience spanning various global leadership roles since joining Evonik in 1996, d’Hervé brings a wealth of expertise in manufacturing, finance, marketing, and strategic alliances to his new position.

(PRESS RELEASE) ESSEN, 2-Jul-2024 — /EuropaWire/ — Effective July 1st, Yann d’Hervé will take the helm of Evonik’s Health Care business line, succeeding his role as Head of the Care Solutions business in the Nutrition & Care division. With a background encompassing roles in manufacturing, finance, marketing, and global sales, d’Hervé brings extensive international management experience to his new position.

Having joined REXIM SAS (now part of Evonik’s Health Care division) in 1996, d’Hervé’s career path has included significant leadership roles in the U.S. and Germany. His tenure has seen him drive strategic alliances and enhance customer satisfaction through value-focused initiatives across Evonik’s global operations.

Evonik Health Care collaborates with pharmaceutical, medical, and nutritional industries worldwide, leveraging a diverse portfolio of ingredients, delivery systems, and contract services to deliver impactful solutions for health and well-being.

Company information

Evonik is one of the world leaders in specialty chemicals. The company is active in more than 100 countries around the world and generated sales of €18.5 billion and an operating profit (adjusted EBITDA) of €2.49 billion in 2022. Evonik goes far beyond chemistry to create innovative, profitable, and sustainable solutions for customers. About 34,000 employees work together for a common purpose: We want to improve life today and tomorrow.

About Nutrition & Care

The focus of the business of the Nutrition & Care division is on health and quality of life. It develops differentiated solutions for active pharmaceutical ingredients, medical devices, nutrition for humans and animals, personal care, cosmetics, and household cleaning. In these resilient end markets, the division generated sales of €4.24 billion in 2022 with about 5,700 employees.


In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.

Media Contacts:

Janusz Berger
Head of Market Communications
Health Care
Phone: +49 6151 18-4984

Dr. Jürgen Krauter
Head of Market Communications
Phone: +49 6181 59-6847

SOURCE: Evonik


Follow EuropaWire on Google News

Comments are closed.